Literature DB >> 16149868

Technical issues in DNA microarray production and utilization: impact on clinical research.

Michael D Kane1.   

Abstract

The adoption and utilization of genomic technologies in healthcare requires that many issues surrounding the integrity of these assay platforms, as well as their overall impact on human health, be definitive. Many concerns common to DNA microarray production must be addressed to exploit the high-content screening capabilities of this assay platform for both genotyping and gene expression profiling in the clinic. Equally important to the success of genomic technology in healthcare is the development of a supporting information system that offers impact at both the personal and population level, and facilitates the adoption, use and, ultimately, impact of genomic information in therapeutic decision support.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16149868     DOI: 10.1586/14737159.5.5.649

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  2 in total

1.  The ABRF MARG microarray survey 2005: taking the pulse of the microarray field.

Authors:  Kevin L Knudtson; Herbert Auer; Andrew I Brooks; Chandi Griffin; George Grills; Susan Hester; Gregory Khitrov; Kathryn S Lilley; Aldo Massimi; Jay P Tiesman; Agnes Viale
Journal:  J Biomol Tech       Date:  2006-04

2.  Detection and genotyping of Campylobacter jejuni and Campylobacter coli by use of DNA oligonucleotide arrays.

Authors:  Francesca Marotta; Katiuscia Zilli; Alfreda Tonelli; Lorena Sacchini; Alessandra Alessiani; Giacomo Migliorati; Elisabetta Di Giannatale
Journal:  Mol Biotechnol       Date:  2013-02       Impact factor: 2.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.